Abstract CT100: Safety and efficacy of AZD8853, an anti-growth and differentiation factor 15 (GDF15) antibody, in patients (pts) with advanced/metastatic solid tumors: First-in-human study
Carneiro, Benedito A., Gbolahan, Olumide, Razak, Albiruni Abdul, Hilton, John F., Lambert, Arthur, Hood, John, Pluta, Michael, Bragulat, Veronique, Sanai, Elhan, Kumar, Rakesh, Jodrell, Duncan, LoRusso, Patricia
Published in Cancer research (Chicago, Ill.) (05.04.2024)
Published in Cancer research (Chicago, Ill.) (05.04.2024)
Get full text
Journal Article
Abstract CT116: First-in-human study of AZD8853, an anti-growth and differentiation factor 15 (GDF15) antibody, in patients (pts) with advanced/metastatic solid tumors
Carneiro, Benedito A., Diab, Maria, Van Tine, Brian A., Shields, Anthony F., Razak, Albiruni Abdul, Hilton, John F., Santana-Davila, Rafael, Sanai, Elhan, Zeron-Medina, Jorge, Bragulat, Veronique, Lowery, Kath, Lambert, Arthur, Hood, John, Kumar, Rakesh, Jodrell, Duncan, LoRusso, Patricia
Published in Cancer research (Chicago, Ill.) (14.04.2023)
Published in Cancer research (Chicago, Ill.) (14.04.2023)
Get full text
Journal Article
Abstract CT222: Efficacy and safety of ceralasertib in the PLANETTE study in patients (pts) with ATM-altered advanced solid tumors (ASTs) or metastatic castration-resistant prostate cancer (mCRPC)
Aggarwal, Rahul, Italiano, Antoine, Domchek, Susan, Goodman, Oscar, Postel-Vinay, Sophie, Garcia-Donas, Jesus, Dorff, Tanya, Reichert, Zachery, Cassier, Philippe, Shore, Neal, Marshall, Catherine, Parr, Graeme, Irurzun-Arana, Itziar, Shah, Neel, Lukashchuk, Natalia, Murina, Olga, Slade, Daniel, Loembé, Bienvenu, Dean, Emma, Sanai, Elhan, Abida, Wassim
Published in Cancer research (Chicago, Ill.) (05.04.2024)
Published in Cancer research (Chicago, Ill.) (05.04.2024)
Get full text
Journal Article
Abstract CT198: Immunomodulatory effects of the ATR inhibitor ceralasertib in a window of opportunity biomarker trial in patients with head and neck squamous cell carcinoma
Jones, Gemma N., Iyer, Sonia, Milo, Marta, Lou, Pei-Jen, Nance, Melonie A., Gomez-Roca, Carlos A., Standifer, Nathan, Marco-Casanova, Paola, Gill, Shaan, Surace, Michael, Bystry, Richard, Alexandrova, Maria, Willis, Sophie, Rodriguez-Canales, Jaime, Dannhorn, Andreas, Loembé, Bienvenu, Lau, Alan, Lukashchuk, Natalia, Harrington, Elizabeth A., Sanai, Elhan, Dean, Emma, Duvvuri, Umamaheswar
Published in Cancer research (Chicago, Ill.) (14.04.2023)
Published in Cancer research (Chicago, Ill.) (14.04.2023)
Get full text
Journal Article
Abstract CT201: Ceralasertib and olaparib in the treatment of homologous recombination repair (HRR)-deficient platinum-sensitive ovarian cancer after progression on PARP inhibitors
Shapiro, Geoffrey I., Basu, Bristi, El-Khoueiry, Anthony, Postel-Vinay, Sophie, Im, Seock-Ah, Rha, Sun Young, Friedman, Claire F., Italiano, Antoine, Kim, Yong Man, Lim, Myong Cheol, Roux, Rene, Liu, Joyce F., Sanai, Elhan, Smith, Simon A., Smith, Claire, Farhi, Sarah El, Lau, Alan, Lukashchuk, Natalia, Dean, Emma, Krebs, Matthew G.
Published in Cancer research (Chicago, Ill.) (15.06.2022)
Published in Cancer research (Chicago, Ill.) (15.06.2022)
Get full text
Journal Article